131 related articles for article (PubMed ID: 8837368)
1. Detection of serum antibodies against Chlamydia pneumoniae by in vitro neutralization and microimmunofluorescence assays.
Donati M; Rumpianesi F; Pavan G; D'Apote L; Cevenini R
Zentralbl Bakteriol; 1996 Jun; 284(1):52-7. PubMed ID: 8837368
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two microimmunofluorescence tests for detecting antibodies to Chlamydia pneumoniae.
Monno R; Sibilio G; Costi A; D'Aprile A; De Vito D; Marcuccio P; Rizzo G
New Microbiol; 2002 Jul; 25(3):299-306. PubMed ID: 12173771
[TBL] [Abstract][Full Text] [Related]
3. Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany.
Jantos C; Artelt P; Schiefer HG
Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):33-5. PubMed ID: 8462558
[TBL] [Abstract][Full Text] [Related]
4. Detection of serum antibodies against Chlamydia pneumoniae by ELISA.
Numazaki K; Ikebe T; Chiba S
FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):179-83. PubMed ID: 8809554
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae serology: comparing a commercial enzyme immunoassay and microimmunofluorescence test in patients with cardiovascular disease.
Vainas T; De Graaf R; Stassen FR; Kurvers HA; Grauls GE; Kitslaar PJ; Bruggeman CA
APMIS; 2003 Feb; 111(2):363-9. PubMed ID: 12716394
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.
Halvorsen DS; Børvik T; Njølstad I; Gutteberg TJ; Vorland LH; Hansen JB
J Intern Med; 2002 Feb; 251(2):142-7. PubMed ID: 11905590
[TBL] [Abstract][Full Text] [Related]
7. A new microimmunofluorescence test for the detection of Chlamydia pneumoniae specific antibodies.
Fernández F; Gutiérrez J; Mendoza J; Linares J; Soto MJ
J Basic Microbiol; 2004; 44(4):275-9. PubMed ID: 15266599
[TBL] [Abstract][Full Text] [Related]
8. Serum reactivity to Chlamydia trachomatis and C. pneumoniae antigens in patients with documented infection and in healthy children by microimmunofluorescence and immunoblotting techniques.
Gonen R; Shemer-Avni Y; Csángó PA; Sarov B; Friedman MG
APMIS; 1993 Sep; 101(9):719-26. PubMed ID: 8240791
[TBL] [Abstract][Full Text] [Related]
9. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae.
Wong YK; Sueur JM; Fall CH; Orfila J; Ward ME
J Clin Pathol; 1999 Feb; 52(2):99-102. PubMed ID: 10396235
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease.
Mendall MA; Carrington D; Strachan D; Patel P; Molineaux N; Levi J; Toosey T; Camm AJ; Northfield TC
J Infect; 1995 Mar; 30(2):121-8. PubMed ID: 7636277
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections.
Frikha-Gargouri O; Znazen A; Gdoura R; Gargouri B; Arab NB; Jemaa MB; Hammami A
Pathol Biol (Paris); 2008 May; 56(3):143-7. PubMed ID: 18178034
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods.
Paldanius M; Leinonen M; Virkkunen H; Tenkanen L; Sävykoski T; Mänttäri M; Saikku P
Diagn Microbiol Infect Dis; 2006 Nov; 56(3):233-9. PubMed ID: 16757141
[TBL] [Abstract][Full Text] [Related]
13. IgG subclass-specific antibodies in Chlamydia pneumoniae infections.
Anttila T; Leinonen M; Surcel HM; Von Hertzen L; Bloigu A; Seppälä I; Saikku P
Scand J Infect Dis; 1998; 30(4):381-6. PubMed ID: 9817519
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci.
Persson K; Haidl S
APMIS; 2000 Feb; 108(2):131-8. PubMed ID: 10737458
[TBL] [Abstract][Full Text] [Related]
15. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation.
Wang Sp
J Infect Dis; 2000 Jun; 181 Suppl 3():S421-5. PubMed ID: 10839728
[TBL] [Abstract][Full Text] [Related]
16. [Isolation of Chlamydia pneumoniae from a patient with acute bronchitis].
Kanamoto Y; Sakano T
Kansenshogaku Zasshi; 1992 May; 66(5):637-42. PubMed ID: 1402098
[TBL] [Abstract][Full Text] [Related]
17. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.
Hoymans VY; Bosmans JM; Van Renterghem L; Mak R; Ursi D; Wuyts F; Vrints CJ; Ieven M
J Clin Microbiol; 2003 Sep; 41(9):4049-53. PubMed ID: 12958224
[TBL] [Abstract][Full Text] [Related]
18. Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.
Tapia O; Slepenkin A; Sevrioukov E; Hamor K; de la Maza LM; Peterson EM
Clin Diagn Lab Immunol; 2002 May; 9(3):562-7. PubMed ID: 11986260
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia pneumoniae serological status is not associated with asthma in children or young adults.
Mills GD; Lindeman JA; Fawcett JP; Herbison GP; Sears MR
Int J Epidemiol; 2000 Apr; 29(2):280-4. PubMed ID: 10817126
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays.
Tuuminen T; Varjo S; Ingman H; Weber T; Oksi J; Viljanen M
Clin Diagn Lab Immunol; 2000 Sep; 7(5):734-8. PubMed ID: 10973446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
